Q3 EPS Estimates for Gossamer Bio Lowered by Leerink Partnrs

Gossamer Bio, Inc. (NASDAQ:GOSS – Free Report) – Equities research analysts at Leerink Partnrs dropped their Q3 2025 earnings per share (EPS) estimates for shares of Gossamer Bio in a research note issued on Wednesday, August 6th. Leerink Partnrs analyst J. S…

Read Full Article →